- Strachan Syndrome
- Mirtazapine
- Anticholinergic Burden
- OSA and Chronic Pain
- Alcohol and Chronic Pain
- Methadone
- Menopause and Chronic Pain
- Chronic Daily Headache
- Indomethacin Responsive Headaches
- Chronic Pain Assessment
- Lacertus Syndrome
- Caloric Vestibular Stimulation
- Idiopathic Intracranial Hypertension
- Intersection Syndrome
- Neuronopathies
- Thoracic Hyperkyphosis
- Developmental Dysplasia of the Hip
- Shin Pain
- Post-Inguinal Hernia Repair Chronic Pain
- Ilioinguinal and Iliohypogastric Nerve Injection
Main Page
From WikiMSK
WELCOME TO WIKIMSK
Nau mai, haere mai! This website is a learning resource that is primarily designed for Musculoskeletal Medicine training in New Zealand. It also aims to be useful for GPs, other doctors, and medical students. It is not written for patients but they are welcome to read the articles. Click on a body region on the skeleton or a portal below to get started.
Portals
Regions ยท Concepts ยท Procedures ยท DDX ยท Cases ยท EBQs ยท Links
Trainee Portal ยท Members Portal ยท AAMM Portal
Trainee Portal ยท Members Portal ยท AAMM Portal
Featured Wiki Article for 1 October 2024
Medicinal Cannabis
The evidence does not support the use of medicinal cannabis in Musculoskeletal Medicine - it is not effective for pain and it may in fact lower pain thresholds. - Read More
New and Updated Articles
- Strachan Syndrome
- Mirtazapine
- Anticholinergic Burden
- Buffered Local Anaesthetic
- Carbamazepine
- OSA and Chronic Pain
- Obesity and Chronic Pain
- Knee Osteoarthritis
- Lateral Femoral Cutaneous Nerve Entrapment
- Lateral Femoral Cutaneous Nerve Injection
- Hip Osteoarthritis
- Antihistamines
- Histamine
- Menopause and Chronic Pain
- Placebo
- Sacroiliac Joint Injection
- Alcohol and Chronic Pain
- Smoking and Chronic Pain
- Leg Cramps
- Medicinal Cannabis
Featured Open Access Journal Article for 1 November 2024
Open-Label Placebo Injection for Chronic Back Pain With Functional Neuroimaging
JAMA Psychiatry
ABSTRACT - In this randomized clinical trial of 101 adults with chronic back pain, an open-label subcutaneous placebo (saline) injection led to significant improvements in pain intensity, mood, and sleep at 1 month posttreatment compared with usual care. The placebo treatment also led to reduced somatomotor activity and increased medial prefrontal activity during evoked back pain and to increased medial prefrontal-brainstem functional connectivity during spontaneous pain.
“I will respect the hard-won scientific gains of those physicians in whose steps I walk, and gladly share such knowledge as is mine with those who are to follow.”
— The Hippocratic Oath: Modern Version, Lasagna 1964